Director, Country Operations Disease Area Lead (Alexion)
AstraZeneca
This listing was originally posted on AstraZeneca's careers page. Formulate is an equal opportunity job aggregator and is not involved in the hiring process. Where salary information is estimated, it is derived from BLS industry benchmarks and may differ from actual compensation.
Upgrade to Pro to access the AI-generated 'Read before applying' briefing and other premium pharma intelligence.
Upgrade to Pro — $25/moDirector, Country Operations Disease Area Lead
Location: Warsaw
Hybrid Model: 3 days per week from office
As Director, Country Operations Disease Area Lead (CODAL) you will provide strategic and operational expertise in assigned disease areas to global and country teams to shape optimal strategy and delivery approaches by the site management organization.
You will maintain oversight of Alexion Rare Disease portfolio key objectives and achievements for your assigned disease areas and play a key role in supporting the appropriate translation of TA strategy to operational delivery across Alexion Country Operations Management (COM) and AZ Site Management and Monitoring (SMM) functions. In this capacity, you will serve as the central point of contact for the disease area within the country organization, supporting operational planning, delivery and issue resolution.
As the primary country operations representative for your assigned disease area, you will maintain a connection between the global stakeholders and the country organization to drive consistent delivery of high-quality trials across the full lifecycle of studies (i.e. early planning, feasibility, start-up, conduct, close-out and reporting).
Collaboration and partnership are key in this position, and a pivotal accountability is to stay updated on internal and external clinical development trends. You will also be required to engage with partners across the full portfolio at the global, regional and country levels.
Responsibilities:
Feasibility:
Collecting and sharing lessons learned:
Input to disease area/indication strategy:
Identifying risks:
Escalation point
Positioning COM / SMM for success:
Requirements:
Essential:
Desirable:
What we offer:
Welcome to Warsaw Site, one of over 400 sites here at AstraZeneca, providing a collaborative environment where everyone feels comfortable and able to be themselves is at the core of AstraZeneca’s priorities, it’s important to us that you bring your full self to work every day.
To help you maintain your best self, here’s a sneak peek into some of the things this site provides for you:
Please note that we are working in a hybrid model of 3 days per week from the office in Warsaw
Date Posted
01-paź-2026Closing Date
14-paź-2026Alexion is proud to be an Equal Employment Opportunity and Affirmative Action employer. We are committed to fostering a culture of belonging where every single person can belong because of their uniqueness. The Company will not make decisions about employment, training, compensation, promotion, and other terms and conditions of employment based on race, color, religion, creed or lack thereof, sex, sexual orientation, age, ancestry, national origin, ethnicity, citizenship status, marital status, pregnancy, (including childbirth, breastfeeding, or related medical conditions), parental status (including adoption or surrogacy), military status, protected veteran status, disability, medical condition, gender identity or expression, genetic information, mental illness or other characteristics protected by law. Alexion provides reasonable accommodations to meet the needs of candidates and employees. To begin an interactive dialogue with Alexion regarding an accommodation, please contact accommodations@Alexion.com. Alexion participates in E-Verify.
Explore related positions you might be interested in
We'll notify you when matching roles are posted.
Interviewed at AstraZeneca?
Help others prepare — share your experience anonymously.
PHARMACEUTICAL
Small Molecules, Vaccines, Biologics
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/mo